0.296
+0.011
(3.86%)
Real-time:
1:17pm BST
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | 0.27 - 0.30 |
| 52 week | 0.25 - 0.79 |
| Open | 0.28 |
| Vol / Avg. | 4.67M/6.45M |
| Mkt cap | 5.64M* |
| P/E | - |
| Div/yield | - |
| EPS | 0.00* |
| Shares | 1,905.17M |
| Beta | - |
| Inst. own | - |
| *GBP |
Key stats and ratios
| Q2 (Jun '12) | 2011 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | -8.85% | -29.90% |
| Return on average equity | -9.47% | -31.05% |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
Orogen Gold plc, formerly Medavinci plc, is engaged in investing in mineral exploration and production of gold projects. The Company focuses on Deli Jovan Project. The Company has an option to earn 55% of the Deli Jovan gold project in Serbia. The Deli Jovan project comprises a number of narrow, gold bearing quartz veins along an 8-10 kilometers shear zone. Prior to March 2011, the Company was engaged in investing in health and wellness based companies. In March 2011, the Company acquired remaining 51% interest in Orogen Gold Limited.
Officers and directors
| Edward Slowey | Chief Executive Officer, Executive Director | |
| Alan Mooney | Finance Director, Executive Director | |
| Paul Andrew Peter Foulger | Company Secretary | |
| John P. Barry | Non-Executive Chairman of the Board | |
| Michael Henry Nolan | Non-Executive Director | |
| Adam Reynolds | Non-Executive Director |